STERIS (STE) Dips On New Restructuring Plan, Layoff Decision
Zacks Investment Research | Dec 05, 2018 10:04PM ET
STERIS plc (NYSE:STE) recently came out with a targeted restructuring plan including the closure of certain manufacturing facilities and a massive layoff. Following the news on Dec 4, shares of the company have slipped 0.93% to close at $119.19 the same day.
The company planned for this restructure due to a reduction in demand for certain products and its overall capacity in the global manufacturing network. Its strategic move includes the disbanding of two manufacturing facilities in Brazil and England. Other actions comprise rationalization of select product offerings and consolidation of manufacturing of others.
The company intends to shift the production of the affected products to existing manufacturing operations by fiscal 2020. The plan also considers an elimination of 200 job positions. Majority of the employees, who might be impacted by this decision, have already been notified about it.
However, the company is optimistic about this targeted restructuring scheme to emerge as a success. An efficient execution of this proposal should lead to an improvement in the company’s quality, delivery and costs.
The plan will incur a restructuring charge of approximately $45 million in fiscal 2019 related to the respective actions undertaken, which will be excluded from the company’s adjusted earnings per share. Profit growth from these actions is projected to be approximately $12 million a year with about half of the benefits occurring in fiscal 2020 and the balance in fiscal 2021.
Notably, with the acquisition of Synergy Health, the U.K.-based outsourced sterilization services provider, STERIS has become the new global leader in infection prevention and sterilization. This consolidation has in turn, boosted STERIS' presence in the international markets as it combined the acquirer’s North American foothold with the acquired entity's solid footprint across Europe. The buyout has also provided STERIS with an opportunity to better serve the emerging markets of Asia-Pacific and Latin America.
However, the shutdown of manufacturing facilities in Brazil and England may dent the global base of STERIS initially. We currently remain on the sidelines to wait and see how this decision can work for STERIS over a longer term.
Price Performance
Year to date, shares of STERIS have outperformed its Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.